Federal regulators have greenlit an expanded application for the weight-loss medication Wegovy, allowing it to be utilized in reducing the risk of stroke, heart attacks, and other severe cardiovascular complications in patients grappling with overweight or obesity, announced the U.S. Food and Drug Administration on Friday. The regulatory decision follows a label change request from … Read more